Literature DB >> 20044749

Prediction of LT4 replacement dose to achieve euthyroidism in subjects undergoing total thyroidectomy for benign thyroid disorders.

Ranjith Sukumar1, Amit Agarwal, Sushil Gupta, Anjali Mishra, Gaurav Agarwal, A K Verma, S K Mishra.   

Abstract

BACKGROUND: Total thyroidectomy is becoming the preferred choice of treatment in patients with benign disorders of the thyroid gland; hence, an optimal method of replacing thyroxine is essential to avoid the ill effects of over- and under-replacement of thyroxine in such patients. PATIENTS AND METHODS: We analyzed three methods of thyroxine replacement: replacement per kilogram of lean body mass (LBM) (2.5 mcg/kg LBM per day), per kilogram of body weight (1.6 mcg/kg body weight per day), and empirical replacement of thyroxine.
RESULTS: The thyroxine requirement in thyroidectomized patients was 2.04 mcg/kg per day, with an increasing requirement of thyroxine with increments of weight. On multivariate analysis we found that the thyroxine requirement was strongly correlated both with body surface area (BSA) and with body weight. On subsequent correlation testing, we found that BSA was more strongly associated than weight with the thyroxine requirement.
CONCLUSIONS: Patients undergoing total thyroidectomy may require higher doses of thyroxine to achieve euthyroidism when compared to patients with similar anthropometric parameters having primary hypothyroidism. The method of replacing thyroxine based on LBM is the ideal method, but replacement based on fixed-dose regimens could be a good method if the body weight is taken into consideration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20044749     DOI: 10.1007/s00268-009-0345-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  17 in total

1.  Thyroid function is more strongly associated with body impedance than anthropometry in healthy subjects.

Authors:  A Sartorio; S Ferrero; L Trecate; G Bedogni
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

2.  Reappraisal of thyroxine treatment in primary hypothyroidism.

Authors:  S Hodges; B P O'Malley; B N Northover; K L Woods; P G Swift
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

3.  Subclinical thyroid dysfunction as a risk factor for cardiovascular disease.

Authors:  John P Walsh; Alexandra P Bremner; Max K Bulsara; Peter O'Leary; Peter J Leedman; Peter Feddema; Valdo Michelangeli
Journal:  Arch Intern Med       Date:  2005-11-28

4.  Optimization of thyroxine replacement therapy after total or near-total thyroidectomy for benign thyroid disease.

Authors:  O Olubowale; D R Chadwick
Journal:  Br J Surg       Date:  2006-01       Impact factor: 6.939

5.  Total thyroidectomy. The preferred option for multinodular goiter.

Authors:  T S Reeve; L Delbridge; A Cohen; P Crummer
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

Review 6.  Thyroid hormone replacement therapy.

Authors:  W M Wiersinga
Journal:  Horm Res       Date:  2001

7.  Assessment of human body composition using dual-energy x-ray absorptiometry and bioelectrical impedance analysis.

Authors:  M Bolanowski; B E Nilsson
Journal:  Med Sci Monit       Date:  2001 Sep-Oct

8.  Effects of thyroxine replacement on lipid profile and endothelial function after thyroidectomy.

Authors:  Y Erbil; N Ozbey; M Giriş; A Salmaslioğlu; S Ozarmağan; S Tezelman
Journal:  Br J Surg       Date:  2007-12       Impact factor: 6.939

9.  Levothyroxine replacement dose for primary hypothyroidism decreases with age.

Authors:  R L Rosenbaum; U S Barzel
Journal:  Ann Intern Med       Date:  1982-01       Impact factor: 25.391

10.  Levothyroxine replacement therapy in patients with subclinical hypothyroidism and coronary artery disease.

Authors:  Valentin V Fadeyev; Julia Sytch; Viktor Kalashnikov; Alexander Rojtman; Abram Syrkin; Galina Melnichenko
Journal:  Endocr Pract       Date:  2006 Jan-Feb       Impact factor: 3.443

View more
  7 in total

1.  Stable Isotope Pharmacokinetic Studies Provide Insight into Effects of Age, Sex, and Weight on Levothyroxine Metabolism.

Authors:  Islam R Younis; Mariam A Ahmed; Kenneth D Burman; Offie P Soldin; Jacqueline Jonklaas
Journal:  Thyroid       Date:  2018-01-02       Impact factor: 6.568

2.  Using body mass index to predict optimal thyroid dosing after thyroidectomy.

Authors:  Kristin A Ojomo; David F Schneider; Alexandra E Reiher; Ngan Lai; Sarah Schaefer; Herbert Chen; Rebecca S Sippel
Journal:  J Am Coll Surg       Date:  2013-01-11       Impact factor: 6.113

3.  The optimal dosing scheme for levothyroxine after thyroidectomy: A comprehensive comparison and evaluation.

Authors:  Nick A Zaborek; Andy Cheng; Joseph R Imbus; Kristin L Long; Susan C Pitt; Rebecca S Sippel; David F Schneider
Journal:  Surgery       Date:  2018-11-06       Impact factor: 3.982

4.  Detection of Polyethylene Glycol Thyrotropin (TSH) Precipitable Percentage (Macro-TSH) in Patients with a History of Thyroid Cancer.

Authors:  Massimo Giusti; Lucia Conte; Anna Maria Repetto; Stefano Gay; Paola Marroni; Miranda Mittica; Michele Mussap
Journal:  Endocrinol Metab (Seoul)       Date:  2017-12

5.  Comparison of the Efficacy of Levothyroxine Suppression Dose Computed Based on Actual Body Weight vs. Lean Body Mass among Differentiated Thyroid Cancer Patients: A Randomized Controlled Trial.

Authors:  Johanna Lu; Reynaldo Rosales; Oliver Allan Dampil
Journal:  J ASEAN Fed Endocr Soc       Date:  2019-11-10

6.  Optimized Replacement T4 and T4+T3 Dosing in Male and Female Hypothyroid Patients With Different BMIs Using a Personalized Mechanistic Model of Thyroid Hormone Regulation Dynamics.

Authors:  Mauricio Cruz-Loya; Benjamin B Chu; Jacqueline Jonklaas; David F Schneider; Joseph DiStefano
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

7.  Variation in the biochemical response to l-thyroxine therapy and relationship with peripheral thyroid hormone conversion efficiency.

Authors:  John E M Midgley; Rolf Larisch; Johannes W Dietrich; Rudolf Hoermann
Journal:  Endocr Connect       Date:  2015-12       Impact factor: 3.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.